Raleigh-based Aniluxx Biotechnology raises $200,000 to develop topicals for animals
Two investors contributed to the round, according to the recent SEC filing. The round is capped at $750,000 with $550,000 remaining to be sold.
Read More
Aniluxx Biotechnology
